Abstract:Palladin was identified to be specifically expressed in the cytomembrane of patients with NSCLC, suggesting its potential as a cell surface marker for LCSCs identification. More importantly, we demonstrated that Palladin might serve as a tumor oncogene and promote the biological properties of LCSCs, possibly by activating the Wnt/β‐catenin signaling in NSCLC for the first time. The elucidation of this new molecular mechanism for Palladin and Wnt/β‐catenin signaling activation is conducive to understand the pathogenesis of NSCLC, providing a novel possibility of the development of novel therapeutic target for CSCs targeted therapy. Background Cancer stem cells (CSCs) are responsible for drug resistance, cancer relapse, and metastasis. Here, we report the first analysis of Palladin expression and its impacts on stem cell‐like properties in lung cancer. Methods Tissue microarrays were used to investigate Palladin expression and its association with prognosis. Immunofluorescence (IF), flow fluorescence assay, and Western blot were performed to detect Palladin expression in 6 NSCLC cell lines. Cell phenotypes and drug resistance were evaluated. Xenograft models were constructed to confirm the role of Palladin in vivo. Results By using the tissue microarrays, Palladin was identified to be highly expressed in the cytoplasm, specifically in the cytomembrane of NSCLC, and its high expression is associated with poor prognosis. Palladin is widely expressed and enriched in the sphere cells. The in vitro and in vivo studies showed that Palladin promoted stem cell‐like properties, including cell viability, invasion, migration, self‐renewal abilities, taxol resistance, and tumorigenicity. Western blot revealed that Palladin promoted the accumulation of β‐catenin and activated Wnt/β‐catenin signaling. Tissue microarrays analysis further confirmed the positive correlation between Palladin and β‐catenin. Wnt/β‐catenin pathway inhibitor blocked the Palladin‐induced enhancement of sphere‐forming. Conclusions Palladin might act as an oncogene by promoting CSCs‐like properties and tumorigenicity of NSCLC cells via the Wnt/β‐catenin signaling pathway. Besides, Palladin was identified to have the potential as a cell surface marker for LCSCs identification. These findings provide a possible target for developing putative agents targeted to LCSCs.

Wnt/β-catenin Signaling Pathway in Lung Cancer Stem Cells is a Potential Target for the Development of Novel Anticancer Drugs.

Wnt Signaling Regulates the Stemness of Lung Cancer Stem Cells and Its Inhibitors Exert Anticancer Effect on Lung Cancer SPC-A1 Cells

Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells.

Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells

Constitutive Expression Of Wnt/Beta-Catenin Target Genes Promotes Proliferation And Invasion Of Liver Cancer Stem Cells

Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines

CCAT1 Stimulation of the Symmetric Division of NSCLC Stem Cells Through Activation of the Wnt Signalling Cascade

Inhibition of Wnt/β-catenin Pathway Reverses Multi-Drug Resistance and EMT in Oct4+/Nanog+ NSCLC Cells.

Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies

Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway

Can Lung Cancer Stem Cells Be Targeted for Therapies?

Targeting the Wnt-Regulatory Protein CTNNBIP1 by Microrna-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas.

Advances in Lung Stem Cells and Lung Cancer Stem Cells

Overcoming Wnt–β-catenin Dependent Anticancer Therapy Resistance in Leukaemia Stem Cells

Palladin promotes cancer stem cell‐like properties in lung cancer by activating Wnt/Β‐Catenin signaling

Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt/Beta-catenin Signaling

Wnt Blockers Inhibit the Proliferation of Lung Cancer Stem Cells

Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse

WNT signaling and cancer stemness

[Research Progress in the Therapeutic Strategy Based on Targeting at Lung Cancer Stem Cell].